FDA approves Velcade for patients with previously untreated multiple myeloma -
Millennium reports positive results from Phase III study of myeloma drug -
Millennium Pharmaceuticals (MLNM) Corporate Event Announcement Notice -
Millennium Pharmaceuticals (MLNM) Corporate Event Announcement Notice -
The Maybach Review: Millennium Pharmaceuticals Inc. Review in Progress -
Takeda-Millennium Merger Gets Anti-trust's Early Termination Of Waiting Period - Quick Facts -
Millennium Pharma And Takeda Pharma Report Early Termination Of Hart-Scott-Rodino Waiting Period -
Millennium Pharmaceuticals (MLNM) Corporate Event Announcement Notice -
Millennium Pharmaceuticals (MLNM) Corporate Event Announcement Notice -
Millennium Pharmaceuticals (MLNM) Corporate Event Announcement Notice -
Millennium Pharmaceuticals (MLNM) Corporate Event Announcement Notice -